Thus, isoform A of PR plays the predominant hormone-dependent role in increasing invasiveness of ER+ breast cancer cells at progesterone concentrations that include the entire range of follicular phase, luteal phase and post-menopausal hormone levels, particularly when the cells overexpress PR-A. The gene discussed is ESR1; the disease is breast cancer.